ID: ALA4854093

Max Phase: Preclinical

Molecular Formula: C9H9N3S

Molecular Weight: 191.26

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Nc1ncc(Cc2ccncc2)s1

Standard InChI:  InChI=1S/C9H9N3S/c10-9-12-6-8(13-9)5-7-1-3-11-4-2-7/h1-4,6H,5H2,(H2,10,12)

Standard InChI Key:  VPGXVWDRMUIBTM-UHFFFAOYSA-N

Associated Targets(Human)

Calcium-activated potassium channel subunit alpha-1 435 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 191.26Molecular Weight (Monoisotopic): 191.0517AlogP: 1.71#Rotatable Bonds: 2
Polar Surface Area: 51.80Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.51CX LogP: 1.49CX LogD: 1.49
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.79Np Likeness Score: -1.39

References

1. Qi XL, Jo H, Wang XY, Ji TT, Lin HX, Park CS, Cui YM..  (2021)  Synthesis and BK channel-opening activity of 2-amino-1,3-thiazole derivatives.,  43  [PMID:33964448] [10.1016/j.bmcl.2021.128083]

Source